1 minute read
Jan. 17, 2022
CC-90001: a JNK Inhibitor for Pulmonary Fibrosis
CC-90001
oral JNK2 kinase inhibitor Ph. II candidate for pulmonary fibrosis from HTS and SBDD Journal of Medicinal Chemistry Celgene (Bristol Myers Squibb), San Diego, CA
Reviewer:
Loading...
